Citius Pharmaceuticals, Inc. Unrecognized Tax Benefits that Would Impact Effective Tax Rate
Citius Pharmaceuticals, Inc. (CTXR) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $79.43 thousand as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Income Taxes
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2023-08-14
- 2023-06-30: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $79.43K.
- 2023-03-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $116.44K.
| Period end | Unrecognized Tax Benefits that Would Impact Effective Tax Rate |
|---|---|
| 2023-06-30 | $79.43K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $116.44K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |